Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Hydrochloride Injection vs Ketanest S in Abdominal Surgery Anesthesia
CTR20231333Phase 3Completed
- Sponsor
- Sinopharm Guorui Pharmaceutical
- Start
- May 2023
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Keyzilen in perioperative pain, sponsored by Sinopharm Guorui Pharmaceutical. Primary endpoint: Time to emergence from anesthesia. Started May 2023; status: completed.
02
Drugs
Keyzilen
03
Conditions
perioperative pain
Beyond the preview
Go deeper on CTR20231333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231333.